ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech

CHARLES TOWN, W.Va., Feb. 6 /PRNewswire/ -- ReBuilder Medical Technologies,
Inc. (Pink Sheets: RBRM) a provider of electronic and silver based treatments
for diabetic peripheral neuropathy and Molluscum Contagiosum today announced
it is in the process of changing its name to American Med Tech.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"In an effort to ferret out the suspected naked short sellers and to get an
accurate investor count to help our stock price accurately reflect its real
value, we are changing the name of the company," said David Phillips, Ph.D.
CEO.

Additionally, Dr. Phillips reported: "This will generate a new cusip # and new
stock ticker symbol. This may result in current stockholders submitting their
certificates to exchange for new ones. I suggest that anyone who owns our
stock and has let their broker hold it in a so called 'street name' request to
have their certificates delivered to them so that they can update their
certificates and make sure that their broker actually bought the shares for
them. We have had reports that brokers have sold shares that they do not
actually have."

Finally, Dr. Phillips told reporters today: "We will have much more positive
news to report in the coming days and weeks."

Inquiries can be made at www.americanmedtech.com or www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended and
Section 21E of the Securities Exchange Act of 1934, as amended, which are
intended to be covered by the safe harbors created thereby. Investors are
cautioned that all forward-looking statements involve risks and uncertainty,
including without limitation, the ability of the Company to successfully
implement its turnaround strategy, changes in costs of raw materials, labor,
and employee benefits, as well as general market conditions, competition and
pricing. Although the Company believes that the assumptions underlying the
forward-looking statements contained herein are reasonable, any of the
assumptions could be inaccurate, and therefore, there can be no assurance that
the forward-looking statements included in this letter will prove to be
accurate. In light of the significant uncertainties inherent in the
forward-looking statements included herein, the inclusion of such information
should not be regarded as representation by the Company or any other person
that the objectives and plans of the Company will be achieved. In assessing
forward-looking statements included herein, readers are urged to carefully
read those statements. When used in the Annual Report on Form 10-K, the words
"estimate," "anticipate," "expect," "believe," and similar expressions are
intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.

David Phillips of ReBuilder Medical Technologies, Inc., +1-304-725-2202,
davidphillipsmail@yahoo.com